HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen F Porcella Selected Research

Stephen F Porcella Research Topics

Disease

28Infections
01/2019 - 10/2002
9Relapsing Fever
01/2013 - 02/2003
6Superinfection
01/2019 - 07/2012
5Malaria
12/2018 - 01/2013
4Persistent Infection
10/2017 - 10/2005
3Fibrosis (Cirrhosis)
12/2016 - 03/2008
3Lyme Disease (Disease, Lyme)
05/2006 - 02/2003
3Pharyngitis (Sore Throat)
08/2004 - 04/2003
2HIV Infections (HIV Infection)
01/2019 - 03/2014
2Inflammation (Inflammations)
11/2015 - 06/2005
2Falciparum Malaria (Plasmodium falciparum Malaria)
05/2015 - 01/2013
2Amebiasis (Amoebiasis)
05/2013 - 03/2011
2Communicable Diseases (Infectious Diseases)
02/2010 - 06/2005
2Q Fever (Fever, Q)
03/2009 - 12/2008
1Disease Progression
01/2019
1Syphilis
01/2019
1Neoplasms (Cancer)
01/2018
1Virus Diseases (Viral Diseases)
01/2018
1Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
01/2017
1Coinfection
12/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2016
1Liver Diseases (Liver Disease)
12/2016
1Chronic Granulomatous Disease
11/2015
1WHIM syndrome
02/2015
1Chromothripsis
02/2015
1Cysts
02/2015
1Trachoma
02/2015
1Thrombosis (Thrombus)
09/2014
1Edema (Dropsy)
09/2014
1Asymptomatic Infections
04/2014
1Anthrax
03/2014
1Acquired Immunodeficiency Syndrome (AIDS)
03/2014
1Encephalitis (Encephalitis, Rasmussen)
04/2013
1Schistosomiasis mansoni
01/2013
1Fever (Fevers)
01/2013
1Brucellosis (Malta Fever)
01/2013
1Autoimmune Diseases (Autoimmune Disease)
04/2011
1Entamoebiasis
03/2011
1Plague (Bubonic Plague)
12/2010

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2018 - 04/2002
4AntigensIBA
01/2018 - 06/2006
4Virulence Factors (Pathogenicity Factors)IBA
02/2015 - 10/2002
4CytokinesIBA
04/2014 - 03/2008
3Neutralizing AntibodiesIBA
01/2019 - 01/2017
3VaccinesIBA
01/2019 - 04/2014
3EnzymesIBA
12/2016 - 02/2003
3RNA (Ribonucleic Acid)IBA
05/2016 - 06/2010
3ChemokinesIBA
04/2014 - 03/2010
3DNA (Deoxyribonucleic Acid)IBA
10/2011 - 10/2005
2Immunoglobulin G (IgG)IBA
01/2019 - 08/2009
2artemisinin (artemisinine)IBA
12/2018 - 01/2013
2Viral ProteinsIBA
10/2016 - 06/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2015 - 09/2005
2Interleukin-6 (Interleukin 6)IBA
02/2015 - 04/2014
2AIDS VaccinesIBA
03/2014 - 07/2012
2insulin receptor-related receptor (IRR)IBA
03/2014 - 07/2004
2Leptin ReceptorsIBA
05/2013 - 03/2011
2Interleukin-17 (Interleukin 17)IBA
04/2011 - 12/2010
2Biological ProductsIBA
03/2010 - 02/2010
2glycerophosphodiester phosphodiesteraseIBA
08/2009 - 02/2003
2ElementsIBA
09/2005 - 12/2003
1Immunoglobulin A (IgA)IBA
01/2019
1ArtesunateIBA
12/2018
1Interferon Type IIBA
01/2018
1RestonIBA
01/2017
12- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA
01/2017
1Monoclonal AntibodiesIBA
12/2016
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
12/2016
1simtuzumabIBA
12/2016
1NucleotidesIBA
10/2016
1Pattern Recognition ReceptorsIBA
09/2015
1Messenger RNA (mRNA)IBA
07/2015
13,5-diisopropylsalicylic acid (DIPS)IBA
06/2015
1AntibodiesIBA
05/2015
1Chemokine ReceptorsIBA
02/2015
1Macrophage Colony-Stimulating FactorIBA
02/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2015
1HIV Envelope Protein gp41IBA
09/2014
1Salivary Proteins and PeptidesIBA
09/2014
1Peroxidase (Myeloperoxidase)IBA
09/2014
1CarrageenanIBA
09/2014
1Interleukin-8 (Interleukin 8)IBA
04/2014
1Pharmaceutical PreparationsIBA
04/2014
1Interleukin-10 (Interleukin 10)IBA
04/2014
1Bicarbonates (Hydrogen Carbonate)IBA
03/2014
1Tenofovir (Viread)FDA Link
03/2014
1Anti-Infective Agents (Microbicides)IBA
03/2014
1Glycoproteins (Glycoprotein)IBA
01/2013
1cyclo(Arg-Pro) (CI 4)IBA
07/2012
1InterferonsIBA
04/2011
1LeptinIBA
03/2011
1Glutamine (L-Glutamine)FDA Link
03/2011
1Cytokine Receptors (Cytokine Receptor)IBA
03/2011
1Arginine (L-Arginine)FDA Link
03/2011

Therapy/Procedure

3Therapeutics
12/2018 - 06/2005
2Aftercare (After-Treatment)
12/2016 - 04/2014
1Art Therapy
10/2017
1Mass Drug Administration
01/2017
1Transplantation
02/2015